Dengue Virus Serotype 1 Exported to Japan from Côte d'Ivoire, 2019.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
24 Mar 2021
Historique:
pubmed: 4 8 2020
medline: 9 7 2021
entrez: 4 8 2020
Statut: ppublish

Résumé

Dengue fever outbreaks have been repeatedly reported in Côte d'Ivoire. During the 2019 outbreak, DENV-1 was the predominant strain and phylogenetic analysis of the DENV-1 genome obtained from the present patient who returned to Japan in January 2019 revealed a high homology with the 2013-2014 Southeast Asian strains. In a previous outbreak in 2017, DENV-1 accounted for 5% of the DENV serotypes. The endemic DENV-1 strain in Abidjan in 2019 could be a strain that was imported from Southeast Asia. Dengue virus can spread globally, and imported dengue fever cases could serve as an alert for outbreaks in the exporting country.

Identifiants

pubmed: 32741926
doi: 10.7883/yoken.JJID.2019.303
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-150

Auteurs

Tetsuya Suzuki (T)

Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Satoshi Kutsuna (S)

Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Takato Nakamoto (T)

Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Masayuki Ota (M)

Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Masahiro Ishikane (M)

Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Kei Yamamoto (K)

Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Takahiro Maeki (T)

Department of Virology 1, National Institute of Infectious Diseases, Japan.

Shigeru Tajima (S)

Department of Virology 1, National Institute of Infectious Diseases, Japan.

Eri Nakayama (E)

Department of Virology 1, National Institute of Infectious Diseases, Japan.
QIMR Berghofer Medical Research Institute, Australia.

Satoshi Taniguchi (S)

Department of Virology 1, National Institute of Infectious Diseases, Japan.

Chang-Kweng Lim (CK)

Department of Virology 1, National Institute of Infectious Diseases, Japan.

Masayuki Saijo (M)

Department of Virology 1, National Institute of Infectious Diseases, Japan.

Norio Ohmagari (N)

Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH